We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Motion and morphometry in clinical and nonclinical populations.
NeuroImage 2016 July 16
INTRODUCTION: The relationship between participant motion, demographic variables and MRI-derived morphometric estimates was investigated in autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia and healthy controls. Participant motion was estimated using resting state fMRI and used as a proxy measure for motion during T1w MRI acquired in the same session. Analyses were carried out in scans qualitatively assessed as free from motion-related artifact.
METHODS: Whole brain T1-weighted MRI and resting state fMRI acquisitions from the ABIDE, ADHD-200 and COBRE databases were included in our analyses. Motion was estimated using coregistration of sequential resting state volumes. We investigated if motion is related to diagnosis, age and gender, and scanning site. We further determined if there is a relationship between participant motion and cortical thickness, contrast, and volumetric estimates.
RESULTS: 2141 participants were included in our analyses. Participant motion was higher in all clinical groups compared with healthy controls. Younger (age<20years) and older (age>40years) people move more than individuals aged 20-40years. Increased motion is associated with reduced average cortical thickness (-0.014mm thickness per mm motion, p=0.0014) and cortical contrast (0.77% contrast reduction per mm motion, p=2.16×10(-9)) in scans that have been qualitatively assessed as free from motion artifact. Volumetric estimates were also associated with motion, however the relationships were generally weaker than cortical thickness and contrast and were dependent on the segmentation method used.
CONCLUSIONS: Participant motion is increased in clinical groups and is systematically associated with morphometric estimates. These findings indicate that accounting for participant motion may be important for improving the statistical validity of morphometric studies.
METHODS: Whole brain T1-weighted MRI and resting state fMRI acquisitions from the ABIDE, ADHD-200 and COBRE databases were included in our analyses. Motion was estimated using coregistration of sequential resting state volumes. We investigated if motion is related to diagnosis, age and gender, and scanning site. We further determined if there is a relationship between participant motion and cortical thickness, contrast, and volumetric estimates.
RESULTS: 2141 participants were included in our analyses. Participant motion was higher in all clinical groups compared with healthy controls. Younger (age<20years) and older (age>40years) people move more than individuals aged 20-40years. Increased motion is associated with reduced average cortical thickness (-0.014mm thickness per mm motion, p=0.0014) and cortical contrast (0.77% contrast reduction per mm motion, p=2.16×10(-9)) in scans that have been qualitatively assessed as free from motion artifact. Volumetric estimates were also associated with motion, however the relationships were generally weaker than cortical thickness and contrast and were dependent on the segmentation method used.
CONCLUSIONS: Participant motion is increased in clinical groups and is systematically associated with morphometric estimates. These findings indicate that accounting for participant motion may be important for improving the statistical validity of morphometric studies.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app